Article info
PDFReview
Recommendations on diagnosis and treatment of depression in patients with multiple sclerosis
- Correspondence to Professor Yara Dadalti Fragoso, Department of Neurology, MS Reference Center, Universidade Metropolitana de Santos, Rua da Constituicao 374, Santos, SP CEP 11015-470, Brazil; yara{at}bsnet.com.br
Citation
Recommendations on diagnosis and treatment of depression in patients with multiple sclerosis
Publication history
- First published February 5, 2014.
Online issue publication
July 08, 2014
Article Versions
- Previous version (5 February 2014).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
Other content recommended for you
- Depression in multiple sclerosis: a review
- Endocrine and immune substrates of depressive symptoms and fatigue in multiple sclerosis patients with comorbid major depression
- Monoaminergic network abnormalities: a marker for multiple sclerosis-related fatigue and depression
- Fatigue at time of CIS is an independent predictor of a subsequent diagnosis of multiple sclerosis
- Depression in neurological disorders: Parkinson’s disease, multiple sclerosis, and stroke
- Pathophysiological and cognitive mechanisms of fatigue in multiple sclerosis
- Multiple sclerosis, depression, and suicide
- Neuropsychiatric syndromes of multiple sclerosis
- Longitudinal course of depression symptoms in multiple sclerosis
- Superior effects of natalizumab versus other DMTs on patient-reported outcomes in people with multiple sclerosis